Practical FDA intelligence for medical device and diagnostic professionals
Hopestone Q&RA Intelligence Tools help regulatory affairs and quality assurance professionals analyze public FDA information, identify meaningful trends, compare companies and products, and prepare information for Management Review and regulatory decision-making.
The tools follow a common design framework for company normalization, source traceability, analysis workflows, reporting, and qualified human review.
Available Q&RA Tools
Launch the Hopestone analyzers currently available for use. Each tool follows the same platform design and reporting principles.
FDA Recall Analyzer
Analyze FDA medical device recall activity, compare companies and reporting periods, identify trends, and prepare Management Review-ready outputs.
- Recall trend analysis
- Company and alias normalization
- Peer and period comparison
- CSV and PowerPoint exports
FDA 510(k) Intelligence Analyzer
Analyze 510(k) clearances, review timelines, applicants, product codes, and potentially similar devices.
- Time-to-clearance analysis
- Applicant benchmarking
- Similar-device research
- FOIA request support
FDA Inspection & Form 483 Analyzer
Analyze inspection classifications, Form 483 observations, establishments, investigators, repeat findings, and follow-up actions.
- NAI, VAI, and OAI trends
- FEI and site analysis
- Repeat observation review
- Form 483 and EIR FOIA support
Tool Roadmap
These tools are in development or planned. Their status will be updated as each analyzer moves through development, testing, and release.
Registration, Listing / Company Intelligence
Create the shared company, facility, FEI, owner/operator, alias, subsidiary, and historical-name foundation used across the platform.
- Registration and listing analysis
- Company and facility normalization
- Owner/operator relationships
- User-reviewed company portfolios
FDA MAUDE Intelligence Analyzer
Analyze adverse event reports, device problems, outcomes, manufacturer narratives, product codes, and reporting trends.
- Adverse-event trend analysis
- Product-code review
- Company and peer benchmarking
- Postmarket signal support
FDA Warning Letter & Enforcement Analyzer
Analyze warning letters, untitled letters, cited requirements, compliance topics, companies, facilities, and response timelines.
- Enforcement trend analysis
- Citation topic grouping
- Company and facility comparison
- Follow-up timing
FDA Import Alert Intelligence Analyzer
Analyze import alerts, red-list and green-list status, firms, products, countries, and detention criteria.
- Import alert monitoring
- Firm and product analysis
- Country-level trends
- Status change review
FDA De Novo Intelligence Analyzer
Analyze De Novo classification requests, review timelines, applicants, product codes, special controls, and later 510(k) activity.
- Review timeline analysis
- Applicant benchmarking
- Special-control research
- Downstream 510(k) activity
FDA PMA Intelligence Analyzer
Analyze PMA approvals, supplements, timelines, applicants, device categories, panel information, and post-approval requirements.
- PMA and supplement trends
- Applicant comparison
- Approval timeline analysis
- Post-approval requirement review
Responsible Use
Hopestone Q&RA Intelligence Tools use publicly available regulatory information and are intended to support—not replace—qualified regulatory, quality, clinical, legal, or business judgment. Important conclusions should be verified against authoritative source records.